Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Marchi, Nicola ^a   Granata, Tiziana ^b   Freri, Elena ^b   Ciusani, Emilio ^b   Ragona, Francesca ^b   Puvenna, Vikram ^a   Teng, Quingshan ^a   Alexopolous, Andreas ^a   Janigro, Damir ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; INTERLEUKIN 1BETA; METHYLPREDNISOLONE; PROTEIN S100B; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN ELECTROPHYSIOLOGY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EPILEPTIC STATE; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; NONHUMAN; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RAT; REVIEW; SEIZURE; TREATMENT OUTCOME; ACUTE DISEASE; ANIMAL; ARTICLE; BLOOD; DISEASE MODEL; DRUG EFFECT; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; TIME;

ANIMALIA; RATTUS;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD-BRAIN BARRIER; CHILD; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; HUMANS; PILOCARPINE; RATS; SEIZURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953135552     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018200     Document Type: Review

References (51)

1. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen HW, et al. (2009) Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia.
2. Elkassabany NM, Bhatia J, Deogaonkar A, Barnett GH, Lotto M, et al. (2008) Perioperative complications of blood brain barrier disruption under general anesthesia: a retrospective review. J Neurosurg Anesthesiol 20: 45-48.
3. Korn A, Golan H, Melamed I, Pascual-Marqui R, Friedman A, (2005) Focal cortical dysfunction and blood-brain barrier disruption in patients with Postconcussion syndrome. J Clin Neurophysiol 22: 1-9.
4. Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, et al. (2007) Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 48: 732-742.
5. Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, et al. (2007) TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130: 535-547.
6. Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, et al. (2004) Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 24: 7829-7836.
7. Tomkins O, Friedman O, Ivens S, Reiffurth C, Major S, et al. (2007) Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis 25: 367-377.
8. Oby E, Janigro D, (2006) The blood-brain barrier and epilepsy. Epilepsia 47: 1761-1774.
9. Cornford EM, (1999) Epilepsy and the blood brain barrier: endothelial cell responses to seizures. Adv Neurol 79: 845-862.
10. Cornford EM, Nguyen EV, Landaw EM, (2000) Acute upregulation of blood-brain barrier glucose transporter activity in seizures. Am J Physiol Heart Circ Physiol 279: H1346-H1354.
11. van Vliet EA, da Costa AS, Redeker S, van Schaik R, Aronica E, et al. (2007) Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130: 521-534.
12. Amato C, Elia M, Musumeci SA, Bisceglie P, Moschini M, (2001) Transient MRI abnormalities associated with partial status epilepticus: a case report. Eur J Radiol 38: 50-54.
13. Huang CC, Wai YY, Chu NS, Liou CW, Pang CY, et al. (1995) Mitochondrial encephalomyopathies: CT and MRI findings and correlations with clinical features. Eur Neurol 35: 199-205.
14. Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, et al. (1999) MRI abnormalities associated with partial status epilepticus. Neurology 52: 1021-1027.
15. Paladin F, Capovilla G, Bonazza A, Mameli R, (1998) Utility of Tc 99 m HMPAO SPECT in the early diagnosis of Rasmussen's syndrome. Ital J Neurol Sci 19: 217-220.
16. Paladin F, Bonazza A, Mameli R, Mainardi F, (1999) Cryptogenic temporal lobe epilepsy. semi-quantitative interictal 99 mTc HMPAO SPECT: statistical correlation with clinical data and EEG. Ital J Neurol Sci 20: 237-242.
17. Tan KM, Britton JW, Buchhalter JR, Worrell GA, Lagerlund TD, et al. (2008) Influence of subtraction ictal SPECT on surgical management in focal epilepsy of indeterminate localization: a prospective study. Epilepsy Res 82: 190-193.
18. Alvarez V, Maeder P, Rossetti AO, (2010) Postictal blood-brain barrier breakdown on contrast-enhanced MRI. Epilepsy Behav 17: 302-303.
19. Siemes H, Siegert M, Aksu F, Emrich R, Hanefeld F, et al. (1984) CSF protein profile in infantile spasms. Influence of etiology and ACTH or dexamethasone treatment. Epilepsia 25: 368-376.
20. Grosso S, Farnetani M, Mostardini R, Cordelli D, Berardi R, et al. (2008) A comparative study of hydrocortisone versus deflazacort in drug-resistant epilepsy of childhood. Epilepsy Res 81: 80-85.
21. Sevilla-Castillo RA, Palacios GC, Ramirez-Campos J, Mora-Puga M, Diaz-Bustos R, (2009) Methylprednisolone for the treatment of children with refractory epilepsy. Neuropediatrics 40: 265-268.
22. Verhelst H, Boon P, Buyse G, Ceulemans B, D'Hooghe M, et al. (2005) Steroids in intractable childhood epilepsy: clinical experience and review of the literature. Seizure 14: 412-421.
23. Snead OC III, Benton JW, Myers GJ, (1983) ACTH and prednisone in childhood seizure disorders. Neurology 33: 966-970.
24. Uva L, Librizzi L, Marchi N, Noe F, Bongiovanni R, et al. (2008) Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability. Neuroscience 151: 303-312.
25. Vezzani A, Granata T, (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46: 1724-1743.
26. Marchi N, Oby E, Batra A, Uva L, de Curtis M, et al. (2007) In vivo and in vitro effects of pilocarpine: relevance to ictogenesis. Epilepsia 48: 1934-1946.
27. Carmen J, Okafor K, Ike E, (1993) The effects of lithium therapy on leukocytes: a 1-year follow-up study. J Natl Med Assoc 85: 301-303.
28. Fabene PF, Navarro MG, Martinello M, Rossi B, Merigo F, et al. (2008) A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 14: 1377-1383.
29. Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, et al. (2009) Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 33: 171-181.
30. Sinclair DB, (2003) Prednisone therapy in pediatric epilepsy. Pediatr Neurol 28: 194-198.
31. Marchi N, Teng Q, Ghosh C, Fan Q, Nguyen MT, et al. (2010) Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity. Brain Res.
32. Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, et al. (2003) Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 97: 2806-2813.
33. Hermsen CC, Mommers E, van de WT, Sauerwein RW, Eling WM, (1998) Convulsions due to increased permeability of the blood-brain barrier in experimental cerebral malaria can be prevented by splenectomy or anti-T cell treatment. J Infect Dis 178: 1225-1227.
34. Razani-Boroujerdi S, Behl M, Hahn FF, Pena-Philippides JC, Hutt J, et al. (2008) Role of muscarinic receptors in the regulation of immune and inflammatory responses. J Neuroimmunol 194: 83-88.
35. Ivens S, Gabriel S, Greenberg G, Friedman A, Shelef I, (2010) Blood-brain barrier breakdown as a novel mechanism underlying cerebral hyperperfusion syndrome. J Neurol 257: 615-620.
36. Stefan H, Lopes da Silva FH, Loscher W, Schmidt D, Perucca E, et al. (2006) Epileptogenesis and rational therapeutic strategies. Acta Neurol Scand 113: 139-155.
37. Granata T, (2003) Rasmussen's syndrome. Neurol Sci 24 (Suppl 4): S239-S243.
38. Granata T, Gobbi G, Spreafico R, Vigevano F, Capovilla G, et al. (2003) Rasmussen's encephalitis: early characteristics allow diagnosis. Neurology 60: 422-425.
39. Araki T, Otsubo H, Makino Y, Elliott I, Iida K, et al. (2006) Efficacy of dexamathasone on cerebral swelling and seizures during subdural grid EEG recording in children. Epilepsia 47: 176-180.
40. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, et al. (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29: 142-160.
41. Vezzani A, Balosso S, Maroso M, Zardoni D, Noe F, et al. (2010) ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr Opin Investig Drugs 11: 43-50.
42. Leite JP, Cavalheiro EA, (1995) Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res 20: 93-104.
43. Leite JP, Garcia-Cairasco N, Cavalheiro EA, (2002) New insights from the use of pilocarpine and kainate models. Epilepsy Res 50: 93-103.
44. Betz AL, Coester HC, (1990) Effect of steroids on edema and sodium uptake of the brain during focal ischemia in rats. Stroke 21: 1199-1204.
45. Cucullo L, Hallene K, Dini G, Dal Toso R, Janigro D, (2004) Glycerophosphoinositol and dexamethasone improve transendothelial electrical resistance in an in vitro study of the blood-brain barrier. Brain Res 997: 147-151.
46. Gutin PH, (1975) Corticosteroid therapy in patients with cerebral tumors: benefits, mechanisms, problems, practicalities. Semin Oncol 2: 49-56.
47. Rook GA, (1999) Glucocorticoids and immune function. Baillieres Best Pract Res Clin Endocrinol Metab 13: 567-581.
48. Riazi K, Galic MA, Pittman QJ, (2010) Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 89: 34-42.
49. Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, et al. (2010) Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16: 413-419.
50. Blair RE, Deshpande LS, Holbert WH, Churn SB, DeLorenzo RJ, (2009) Age-dependent mortality in the pilocarpine model of status epilepticus. Neurosci Lett 453: 233-237.
51. Rogawski MA, Reddy DS, (2002) Neurosteroids and infantile spasms: the deoxycorticosterone hypothesis. Int Rev Neurobiol 49: 199-219.